Ethema Health Corp (GRST)

[Bubae]

I can point to the FAQ page released July 2021 for how the company defines "Soon". There are four suspect comments in two sentences regarding dilution. "We cannot tell yet how much more conversion there will be", "rate and amount are in a dramatic decline", "end coming soon", and "direction for much of the past three months".

The dilution for each quarter of 2021 is below. Keep in mind that the dilution earlier in2021 was at a much higher price than by the end of the year. Right at one billion new shares dumped in Q3 and Q4 while they claim that it would end soon. People made trading decisions based on information like that.

FAQ Page released July 2021
https://ethema.wpengine.com/?page_id=683

When will the debt be brought under control and when will the dilution stop?

...We cannot tell yet how much more conversion there will be but the rate and amount are in a dramatic decline. We do see an end coming soon since that has been the direction for much of the past three months...

Ethema has added an FAQ section to its website https://t.co/L97AvfEQy0 and has established a forum for frequently asked shareholder questions. $GRST

— Ethema Health (@HealthEthema) July 27, 2021

For the quarterly period ended March 31, 2021
https://www.otcmarkets.com/filing/html?id=14979734&guid=Qum-kp5mwFwMgrh
Authorized and outstanding

The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 2,262,849,130 and 2,027,085,665 shares of common stock at March 31, 2021 and December 31, 2020, respectively

235,763,465 new shares for Q1 2021

For the quarterly period ended June 30, 2021
https://www.otcmarkets.com/filing/html?id=15181522&guid=Qum-kp5mwFwMgrh
Authorized and outstanding

The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 2,601,515,456 and 2,027,085,665 shares of common stock at June 30, 2021 and December 31, 2020, respectively. 338,666,326 shares for Q2

338, 666,326 increase for period Q2 2021


For the quarterly period ended September 30, 2021
https://www.otcmarkets.com/filing/html?id=15373092&guid=Qum-kp5mwFwMgrh
Authorized and outstanding

The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 3,111,047,811 and 2,027,085,665 shares of common stock at September 30, 2021 and December 31, 2020, respectively.

509,532,355 new shares for Q3 2021

For the fiscal year ended: December 31, 2021
https://www.otcmarkets.com/filing/html?id=15732252&guid=Qum-kp5mwFwMgrh

a) Common shares
Authorized and outstanding

The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 3,579,053,805 and 2,027,085,665 shares of common stock at December 31, 2021 and December 31, 2020, respectively.

468,005,994 new shares for Q4 2021